{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:56:15Z","timestamp":1781650575603,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Conventional nodal staging (N stage) and positive lymph node ratio exhibit limitations in accurately evaluating lymph node status. The current research aims to explore the prognostic value of the logarithmic odds of positive lymph nodes (LODDS) for projecting overall survival (OS) and cancer-specific survival (CSS) in patients with cervical cancer (CC) undergoing surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients who received surgical treatment for CC between 2004 and 2020 were identified from the Surveillance, Epidemiology, and End Results database. Propensity score matching (PSM) was applied to balance baseline characteristics. Hazard ratios (HRs) were analyzed employing Cox proportional hazards regression models. The possible nonlinear relationship was evaluated via restricted cubic splines. Survival rates were compared utilizing Kaplan-Meier curves. Subgroup analyses were also conducted. A novel LODDS-based model was established and verified. Its predictive accuracy was compared with that of the conventional Tumor-Node-Metastasis (TNM) staging model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 9,501 subjects were initially enrolled. Following PSM, 2,092 matched cases were encompassed in the analysis cohort. Multivariable analysis indicated that High LODDS was markedly related to elevated risk of mortality (OS: HR 2.04, 95% confidence interval [CI] 1.747\u20132.383; CSS: HR 1.821, 95% CI 1.52\u20132.181;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Model comparison indicated superior predictive performance for the novel LODDS-based model over the conventional model incorporating TNM staging (C-index: 0.743 vs. 0.692). Both the net reclassification improvement and integrated discrimination improvement indices confirmed that the new model offered notably better predictive capability for survival at 1, 3, and 5 years (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001 for all).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LODDS constitutes an independent prognostic factor for individuals with CC following surgery. Compared with conventional TNM staging, LODDS provides incremental prognostic value, facilitating the development of personalized risk assessment and more accurate follow-up strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-026-04353-z","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:06:01Z","timestamp":1776477961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between log odds of positive lymph nodes and survival in surgically treated cervical cancer patients: a SEER database\u2013based cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Lu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"2","key":"4353_CR1","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/s2214-109x(22)00501-0","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197\u2013206. https:\/\/doi.org\/10.1016\/s2214-109x(22)00501-0.","journal-title":"Lancet Glob Health"},{"key":"4353_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A, Cancer statistics. 2023. CA Cancer J Clin. 2023; 73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","DOI":"10.3322\/caac.21763"},{"issue":"4","key":"4353_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1620\/tjem.255.303","volume":"255","author":"S Miyahara","year":"2021","unstructured":"Miyahara S, Tsuji K, Shimada M, Shibuya Y, Shigeta S, Nagai T, et al. The Impact of Histological Subtype on Survival Outcome of Patients with Stage IIB-IVA Cervical Cancer Who Received Definitive Radiotherapy. Tohoku J Exp Med. 2021;255(4):303\u201313. https:\/\/doi.org\/10.1620\/tjem.255.303.","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"4353_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ygyno.2021.05.023","volume":"162","author":"MN Brodeur","year":"2021","unstructured":"Brodeur MN, Dejean R, Beauchemin MC, Samou\u00eblian V, Cormier B, Bacha OM, et al. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer. Gynecol Oncol. 2021;162(2):277\u201383. https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.023.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4353_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12885-021-08209-5","volume":"21","author":"Y Feng","year":"2021","unstructured":"Feng Y, Wang Y, Xie Y, Wu S, Li Y, Li M. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer. BMC Cancer. 2021;21(1):450. https:\/\/doi.org\/10.1186\/s12885-021-08209-5.","journal-title":"BMC Cancer"},{"issue":"4","key":"4353_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jso.21199","volume":"99","author":"LT Gien","year":"2009","unstructured":"Gien LT, Covens A. Lymph node assessment in cervical cancer: prognostic and therapeutic implications. J Surg Oncol. 2009;99(4):242\u20137. https:\/\/doi.org\/10.1002\/jso.21199.","journal-title":"J Surg Oncol"},{"issue":"1","key":"4353_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10147-010-0123-0","volume":"16","author":"M Hosaka","year":"2011","unstructured":"Hosaka M, Watari H, Mitamura T, Konno Y, Odagiri T, Kato T, et al. Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol. 2011;16(1):33\u20138. https:\/\/doi.org\/10.1007\/s10147-010-0123-0.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"4353_CR8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5301\/tj.5000560","volume":"103","author":"B Huang","year":"2017","unstructured":"Huang B, Ni M, Chen C, Cai G, Cai S. LODDS is superior to lymph node ratio for the prognosis of node-positive rectal cancer patients treated with preoperative radiotherapy. Tumori. 2017;103(1):87\u201392. https:\/\/doi.org\/10.5301\/tj.5000560.","journal-title":"Tumori"},{"issue":"6","key":"4353_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/sla.0000000000001040","volume":"262","author":"G Spolverato","year":"2015","unstructured":"Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, et al. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. Ann Surg. 2015;262(6):991\u20138. https:\/\/doi.org\/10.1097\/sla.0000000000001040.","journal-title":"Ann Surg"},{"issue":"1","key":"4353_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijgo.12749","volume":"145","author":"N Bhatla","year":"2019","unstructured":"Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet. 2019;145(1):129\u201335. https:\/\/doi.org\/10.1002\/ijgo.12749.","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 2","key":"4353_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):22\u201336. https:\/\/doi.org\/10.1002\/ijgo.12611.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"4353_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/aog.0000000000003311","volume":"134","author":"JD Wright","year":"2019","unstructured":"Wright JD, Matsuo K, Huang Y, Tergas AI, Hou JY, Khoury-Collado F, et al. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines. Obstet Gynecol. 2019;134(1):49\u201357. https:\/\/doi.org\/10.1097\/aog.0000000000003311.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4353_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41598-019-57202-3","volume":"10","author":"X Liu","year":"2020","unstructured":"Liu X, Wang W, Hu K, Zhang F, Hou X, Yan J, et al. A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System. Sci Rep. 2020;10(1):362. https:\/\/doi.org\/10.1038\/s41598-019-57202-3.","journal-title":"Sci Rep"},{"issue":"16","key":"4353_CR14","doi-asserted-by":"publisher","first-page":"14721","DOI":"10.1007\/s00432-023-05283-z","volume":"149","author":"X Huang","year":"2023","unstructured":"Huang X, Xu X, Xu A, Luo Z, Li C, Wang X, et al. Exploring the most appropriate lymph node staging system for node-positive breast cancer patients and constructing corresponding survival nomograms. J Cancer Res Clin Oncol. 2023;149(16):14721\u201330. https:\/\/doi.org\/10.1007\/s00432-023-05283-z.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4353_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijsu.2016.06.002","volume":"32","author":"B Huang","year":"2016","unstructured":"Huang B, Chen C, Ni M, Mo S, Cai G, Cai S. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database. Int J Surg. 2016;32:24\u201330. https:\/\/doi.org\/10.1016\/j.ijsu.2016.06.002.","journal-title":"Int J Surg"},{"issue":"11","key":"4353_CR16","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1002\/cncr.24989","volume":"116","author":"Z Sun","year":"2010","unstructured":"Sun Z, Xu Y, Li de M, Wang ZN, Zhu GL, Huang BJ, et al. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer. 2010;116(11):2571\u201380. https:\/\/doi.org\/10.1002\/cncr.24989.","journal-title":"Cancer"},{"issue":"5","key":"4353_CR17","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.18632\/oncotarget.14100","volume":"8","author":"XL Xu","year":"2017","unstructured":"Xu XL, Cheng H, Tang MS, Zhang HL, Wu RY, Yu Y, et al. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer. Oncotarget. 2017;8(5):8120\u201330. https:\/\/doi.org\/10.18632\/oncotarget.14100.","journal-title":"Oncotarget"},{"issue":"3","key":"4353_CR18","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/j.clgc.2022.12.001","volume":"21","author":"A Salari","year":"2023","unstructured":"Salari A, Ghahari M, Nowroozi A, Ghahari P, Haddad M, Sahebi L, et al. Log Odds of Positive Lymph Nodes (LODDS) as an Independent Predictor of Overall Survival Following Radical Cystectomy in Urothelial Bladder Cancer: Time to Rethink Conventional Node Staging. Clin Genitourin Cancer. 2023;21(3):e175\u201381. https:\/\/doi.org\/10.1016\/j.clgc.2022.12.001.","journal-title":"Clin Genitourin Cancer"},{"key":"4353_CR19","doi-asserted-by":"publisher","first-page":"1411426","DOI":"10.3389\/fendo.2025.1411426","volume":"16","author":"S Jing","year":"2025","unstructured":"Jing S, Song J, Di Y, Xiao J, Ma J, Wu Z. Construction and validation of novel nomograms based on the log odds of positive lymph nodes to predict the prognosis of papillary thyroid cancer: a retrospective cohort study. Front Endocrinol (Lausanne). 2025;16:1411426. https:\/\/doi.org\/10.3389\/fendo.2025.1411426.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"4353_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.21037\/atm.2020.03.27","volume":"8","author":"Q Guo","year":"2020","unstructured":"Guo Q, Zhu J, Wu Y, Wen H, Xia L, Ju X, et al. Validation of the prognostic value of various lymph node staging systems for cervical squamous cell carcinoma following radical surgery: a single-center analysis of 3,732 patients. Ann Transl Med. 2020;8(7):485. https:\/\/doi.org\/10.21037\/atm.2020.03.27.","journal-title":"Ann Transl Med"},{"key":"4353_CR21","doi-asserted-by":"publisher","first-page":"857375","DOI":"10.3389\/fonc.2022.857375","volume":"12","author":"J Yi","year":"2022","unstructured":"Yi J, Liu Z, Wang L, Zhang X, Pi L, Zhou C, et al. Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis. Front Oncol. 2022;12:857375. https:\/\/doi.org\/10.3389\/fonc.2022.857375.","journal-title":"Front Oncol"},{"key":"4353_CR22","doi-asserted-by":"publisher","first-page":"916310","DOI":"10.3389\/fonc.2022.916310","volume":"12","author":"J Yi","year":"2022","unstructured":"Yi J, Liu Z, Wang L, Zhang X, Pi L, Zhou C, et al. Corrigendum: Development and Validation of Novel Nomograms to Predict the Overall Survival and Cancer-Specific Survival of Cervical Cancer Patients With Lymph Node Metastasis. Front Oncol. 2022;12:916310. https:\/\/doi.org\/10.3389\/fonc.2022.916310.","journal-title":"Front Oncol"},{"issue":"1","key":"4353_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ygyno.2014.04.011","volume":"134","author":"LC Horn","year":"2014","unstructured":"Horn LC, Bilek K, Fischer U, Einenkel J, Hentschel B. A cut-off value of 2\u00a0cm in tumor size is of prognostic value in surgically treated FIGO stage IB cervical cancer. Gynecol Oncol. 2014;134(1):42\u20136. https:\/\/doi.org\/10.1016\/j.ygyno.2014.04.011.","journal-title":"Gynecol Oncol"},{"issue":"9077","key":"4353_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/s0140-6736(97)02250-2","volume":"350","author":"F Landoni","year":"1997","unstructured":"Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350(9077):535\u201340. https:\/\/doi.org\/10.1016\/s0140-6736(97)02250-2.","journal-title":"Lancet"},{"issue":"15","key":"4353_CR25","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1056\/nejm199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144\u201353. https:\/\/doi.org\/10.1056\/nejm199904153401502.","journal-title":"N Engl J Med"},{"issue":"7","key":"4353_CR26","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1097\/igc.0000000000001313","volume":"28","author":"K Huang","year":"2018","unstructured":"Huang K, Jia M, Li P, Han J, Zhang R, Li Q, et al. Radiotherapy Improves the Survival of Patients With Metastatic Cervical Cancer: A Propensity-Matched Analysis of SEER Database. Int J Gynecol Cancer. 2018;28(7):1360\u20138. https:\/\/doi.org\/10.1097\/igc.0000000000001313.","journal-title":"Int J Gynecol Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04353-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04353-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04353-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:19:08Z","timestamp":1781648348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04353-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4353"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04353-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was in accordance with the Declaration of Helsinki. Approval from an ethics committee was unnecessary because the data in SEER are de-identified and publicly accessible.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}